Composition
- Active ingredients
- ISATUXIMAB-IRFC 100MG/5ML (20MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ISATUXIMAB-IRFC 500MG/25ML (20MG/ML) · InjectableBLA761113-002 · Prescription
- ISATUXIMAB-IRFC 100MG/5ML (20MG/ML) · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761113.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Sarclisa
- Active substance
- isatuximab-irfc
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Sanofi Aventis US
- Status
- Prescription
- FDA approval
- 2 Mar 2020
- Application
- BLA761113-001